Haemoglobinopathies in Southeast Asia

Indian Journal of Medical Research

Volumn 134, Issue 10, 2011, Pages 498-506

  Fucharoen, Suthat ^a   Winichagoon, Pranee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

thalassaemia; thalassaemia; Haemoglobin (Hb) E; Hb constant spring (CS)

Indexed keywords

ALPHA GLOBIN; DEFEROXAMINE; FERRITIN; HEMOGLOBIN E; HEMOGLOBIN H; IRON;

ALPHA THALASSEMIA; AWARENESS; BETA THALASSEMIA; BLOOD EXAMINATION; BLOOD TRANSFUSION; CAPILLARY ELECTROPHORESIS; CLINICAL EXAMINATION; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; DISEASE SEVERITY; FERRITIN BLOOD LEVEL; GENE CLUSTER; GENE DELETION; GENE EXPRESSION; GENE INACTIVATION; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC DISORDER; GENETIC SCREENING; GENOTYPE; HEALTH CARE COST; HEALTH EDUCATION; HEMOGLOBIN AE BART DISEASE; HEMOGLOBIN BART HYDROPS FETALIS; HEMOGLOBIN CONSTANT SPRING; HEMOGLOBIN EF BART DISEASE; HEMOGLOBINOPATHY; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOSITY; HUMAN; INDEL MUTATION; INTRON; IRON ABSORPTION; IRON CHELATION; IRON OVERLOAD; LABORATORY DIAGNOSIS; MASS SCREENING; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MEDICAL ABORTION; PHENOTYPE; POINT MUTATION; PRENATAL DIAGNOSIS; PRIMARY PREVENTION; PROMOTER REGION; QUALITY OF LIFE; REVIEW; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHEAST ASIA; THALASSEMIA; TREATMENT PLANNING; UMBILICAL CORD BLOOD;

ALPHA-THALASSEMIA; ASIA, SOUTHEASTERN; BETA-GLOBINS; BETA-THALASSEMIA; GENE DELETION; HEMOGLOBIN E; HEMOGLOBINS, ABNORMAL; HUMANS; POINT MUTATION;

EID: 80455127464     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Abdulla MA, Ahmed I, Assawamakin A, Bhak J, Brahmachari SK, Calacal GC, et al. Mapping human genetic diversity in Asia. Science 2009; 326: 1541-5.
2. Wasi P. Hemoglobinopathies in Southeast Asia. In: Bowman JE, editor. Distribution and evolution of hemoglobin and globin Loci. New York: Elsevier; 1983. p. 179-203.
3. Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia. Hemoglobin 1987; 11: 65-8.
4. Wasi P, Na Nakorn S, Pootrakul S, Sookanek M, Disthansongchan P, Panich V, et al. Alpha- and beta-thalassemia in Thailand. Ann NY Acad Sci 1969; 165: 60-82.
5. Higgs DR, Vickers MA, Wilkie AOM, Pretorius IM, Jarman AP, Weatherall DJ. A review of the molecular genetics of the human α-globin gene cluster. Blood 1989; 73: 1081-104.
6. Thein SL, Winichagoon P, Hesketh C, Best S, Fucharoen S, Wasi P, et al. The Molecular basis of β-thalassemia in Thailand: Application to prenatal diagnosis. Am J Hum Genet 1990; 47: 369-75.
7. Fucharoen S, Winichagoon P, Pootrakul P, Piankijagum A, Wasi P. Variable severity of Southeast Asian β-thalassemia/Hb E disease. Birth Defects 1988; 23 (SA): 241-8.
8. Olivieri NF, Thayalsuthan V, O'Donnell A, Premawardhena A, Rigobon C, Muraca G, et al. Emerging insights in the management of hemoglobin E beta thalassemia. Ann NY Acad Sci 2010; 1202: 155-7.
9. Premawardhena A, Fisher CA, Olivieri NF, de Silva S, Arambepola M, Perera W, et al. Haemoglobin E thalassaemia in Sri Lanka. Lancet 2005; 366: 1467-70.
10. Lie Injo LE, Solai A, Herrera AR, Nicolaisen L, Kan YW, Wan WP, et al. Hb Bart's level in cord blood and deletion of α-globin genes. Blood 1982; 59: 370-6.
11. Winichagoon P, Higgs DR, Goodbourn SEY, Clegg JB, Weatherall DJ, Wasi P. The molecular basis of α-thalassemia in Thailand. EMBO J 1984: 3: 1813-8.
12. Fischel-Ghodsian N, Vickers MA, Seip M, Winichagoon P, Higgs DR. Characterization of two deletions that remove the entire human α-globin gene complex (--THAI and --FIL). Br J Haematol 1988; 70: 233-8.
13. Higgs DR, Garrick D, Anguita E, De Gobbi M, Hughes J, Muers M, et al. Understanding alpha-globin gene regulation: aiming to improve the management of thalassemia. Ann NY Acad Sci 2005; 1054: 92-102.
14. Viprakasit V, Harteveld CL, Ayyub H, Stanley JS, Giordano PC, Wood WG, et al. A novel deletion causing alpha thalassemia clarifies the importance of the major human alpha globin regulatory element. Blood 2006; 107: 3811-2.
15. Flint J, Harding RM, Boyce AJ, Clegg JB. The population genetics of the haemoglobinopathies. Baillieres Clin Haematol 1998; 11: 1-51.
16. Weatherall DJ, Clegg JB, editors. The thassaemia syndromes. 4th ed. Oxford, United Kingdom: Blackwell Science; 2001.
17. Weatherall DJ, Miller LH, Baruch DI, Marsh K, Doumbo OK, Casals-Pascual C, et al. Malaria and the red cell. Hematology Am Soc Hematol Educ Program 2002: 35-57.
18. Liebhaber SA, Cash FE, Ballas SK. Human α-globin gene expression. The dominant role of the α2-locus in mRNA and protein synthesis. J Biol Chem 1986; 261: 15327-33.
19. Liebhaber SA, Cash F, Eshleman SS. Translation inhibition by an mRNA coding region secondary structure is determined by its proximity to the AUG initiation codon. J Mol Biol 1992; 226: 609-21.
20. Viprakasit V, Tanphaichitr VS, Pung-Amritt P, Petrarat S, Suwantol L, Fisher C, et al. Clinical phenotypes and molecular characterization of Hb H-Pakse disease. Haematologica 2002; 87: 117-25.
21. Viprakasit V, Tanphaichitr VS, Veerakul G, Chinchang W, Petrarat S, Pung-Amritt P, et al. Co-inheritance of Hb Pak Num Po, a novel alpha1 gene mutation, and alpha0 thalassemia associated with transfusion-dependent Hb H disease. Am J Hematol 2004; 75: 157-63.
22. Kanokpongsakdi S, Fucharoen S, Vantanasiri C, Thonglairoam V, Winichagoon P, Manassakorn J. Ultrasonographic method for detection of haemoglobin Bart's hydrops fetalis in the second trimester of pregnancy. Prenatal Diagnosis 1990; 10: 809-13.
23. Fucharoen S, Winichagoon P, Thonglairoam V, Siriboon W, Siritanaratkul N, Kanokpongsakdi S, et al. Prenatal diagnosis of thalassemia and hemoglobinopathies in Thailand: Experience from 100 pregnancies. Southeast Asian J Trop Med Public Health 1991; 22: 16-29.
24. Chinprasertsuk S, Piankijagum A, Wasi P. In vivo induction of intraerythrocytic inclusion bodies in hemoglobin H disease: an electron microscopic study. Birth Defects 1988; 23: 317-26.
25. Fucharoen S, Winichagoon P, Pootrakul P, Piankijagum A, Wasi P. Differences between two types of Hb H disease, α-thalassemia 1/α-thalassemia 2 and α-thalassemia 1/Hb Constant Spring. Birth Defects 1988; 23: 309-15.
26. Chan V, Chan TK, Todd D. Different forms of Hb H disease in the Chinese. Hemoglobin 1988; 12: 499-507.
27. Chui DH, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood 2003; 101: 791-800.
28. Fucharoen S, Viprakasit V. Hb H disease: clinical course and disease modifiers. Hematology Am Soc Hematol Educ Program 2009; 26-34.
29. Winichagoon P, Adirojnanon P, Wasi P. Levels of haemoglobin H and proportions of red cells with inclusion bodies in the two types of haemoglobin H disease. Br J Haematol 1980; 46: 507-9.
30. Thonglairoam V, Winichagoon P, Fucharoen S, Tanphaichitr VS, Pung-Amritt P, Embury SH, et al. Hemoglobin Constant Spring in Bangkok: Molecular screening by selective enzymatic amplification of the α2-globin gene. Am J Hematol 1991; 38: 277-80.
31. Fucharoen S, Winichagoon P, Thonglairoam V, Wasi P. EF Bart's disease: interaction of the abnormal α- and β-globin genes. Eur J Haematol 1988; 40: 75-8.
32. Winichagoon P, Fucharoen S, Thonglairoam V, Tanapotiwirut V, Wasi P. β-thalassemia in Thailand. Ann NY Acad Sci 1990; 612: 31-42.
33. Furuumi H, Firdous N, Inoue T, Ohta H, Winichagoon P, Fucharoen S, et al. Molecular basis of β-thalassemia in the Maldives. Hemoglobin 1998; 22: 141-51.
34. Setianingsih I, Williamson R, Dand D, Harahap A, Marzuki S, Forrest S. Phenotypic variability of Filipino β(0)-thalassemia/HbE patients in Indonesia. Am J Hematol 1999; 62: 7-12.
35. Colah R, Gorakshakar A, Nadkarni A, Phanasgaonkar S, Surve R, Sawant P, et al. Regional heterogeneity of β-thalassemia mutations in the multi ethnic Indian population. Blood Cells Molecules Dis 2009; 42: 241-6.
36. Colah R, Gorakshakar A, Phanasgaonkar S, D'Souza E, Nadkarni A, Surve R, et al. Epidemiology of β-thalassaemia in Western India: mapping the frequencies and mutations in sub-regions of Maharashtra and Gujarat. Br J Haematol 2010; 149: 739-47.
37. Traeger J, Winichagoon P, Wood WG. Instability of βE-messenger RNA during erythroid cell maturation in hemoglobin E homozygotes. J Clin Invest 1982; 69: 1050-3.
38. Winichagoon P. Fucharoen S, Weatherall OJ, Wasi P. Concomitant inheritance of α-thalassemia in β-thalassemia/HbE. Am J Hematol 1985: 20: 217-22.
39. Nuntakarn L, Fucharoen S, Fucharoen G, Sanchaisuriya K, Jetsrisuparb A, Wiangnon S. Molecular, hematological and clinical aspects of thalassemia major and thalassaemia intermedia associated with Hb E-beta-thalassemia in Northeast Thailand. Blood Cells Mol Dis 2009; 42: 32-5.
40. Pootrakul P, Vongsmasa V, La-ongpanich P, Wasi P. Serum ferritin levels in thalassemias and the effect of splenectomy. Acta Haematol 1981; 66: 244-50.
41. Pootrakul P, Huebers HA, Finch CA, Pippard MJ, Cazzola M. Iron metabolism in thalassemia. Birth Defects 1988; 23: 3-8.
42. Pootrakul P, Sirankapracha P, Hemsorach S, Moungsub W, Kumbunlue R, Piangitjagum A, et al. A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in Thai patients with thalassemia. Blood 2000; 96: 2606-12.
43. Sonakul D, Pacharee P, Laohaphand T, Fucharoen S, Wasi P. Pulmonary artery obstruction in thalassemia. Southeast Asian J Trop Med Public Health 1980; 11: 516-23.
44. Fucharoen S, Youngchaiyud P, Wasi P. Hypoxaemia and the effect of aspirin in thalassemia. Southeast Asian J Trop Med Public Health 1981; 12: 90-3.
45. Sripichai O, Makarasara W, Munkongdee T, Kumktoek C, Nuchprayoon I, Chuansumrit A, et al. A scoring system for the classification of β-thalassemia/Hb E disease severity. Am J Hematol 2008; 83: 482-4.
46. Nuinoon M, Makarasara W, Mushiroda T, Setianingsih I, Wahidiyat PA, Sripichai O, et al. A genome-wide association identified the common genetic variants influence disease severity in β-thalassemia/hemoglobin E. Hum Genet 2010; 127: 303-14.
47. Gilman JG, Huisman THJ. DNA sequence variation associated with elevated fetal Gg globin production. Blood 1985; 66: 783-7.
48. Labie D, Pagnier J, Lapoumeroulie C, Rouabhi F, Dunda-Belkhodja O, Chardin P, et al. Common haplotype dependency of high Gα-globin gene expression and high Hb F levels in β-thalassemia and sickle cell anemia patients. Proc Natl Acad Sci USA 1985; 82: 2111-4.
49. Thein SL, Menzel S, Peng X, Best S, Jiang J Close J, et al. Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc Natl Acad Sci USA 2007; 104: 11346-51.
50. Lettre G, Sankaran VG, Bezerra MA, Araujo AS, Uda M, Sanna S, et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and β-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci USA 2008; 105: 11869-74.
51. Menzel S, Garner C, Gut I, Masuda F, Yamaguchi M, Heath S, et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat Genet 2007; 39: 1197-9.
52. Sampietro M, Thein SL, Contreras M, Pazmany L. Variation of HbF and F-cell number with the G-gamma Xmn I (C-T) polymorphism in normal individuals. Blood 1992; 79: 832-3.
53. Kuliev AM. The WHO control program for hereditary anemia. Birth Defects 1988; 23: 383-94.
54. Cao A, Rosatelli C. Control of β-thalassemia in Sardinia. Birth Defects 1988; 23: 395-404.
55. Loukopoulos D, Kaltsoya-Tassiopoulou A, Fessas P. Thalassemia control in Greece. Birth Defects 1988; 23: 405-16.
56. Angastiniotis M. Cyprus: thalassemia programme. Lancet 1990; 2: 1119-20.
57. Parnsatienkul B. Thalassemia. In: current situation and strategic plan for prevention and control of blood diseases in Thailand 1989-1990. Bangkok: Num-Aksorn Karnpim; 1990. p. 5-43.
58. Modell B, Berdoukas V. The clinical approach to thalassemia. London: Grone and Stratton; 1984. p. 275-7.
59. Tongsong T, Wanapirak C, Sirivatanapa P, Sanguansermsri T, Sirichotiyakul S, Piyamongkol W, et al. Prenatal control of severe thalassemia: Chiang Mai strategy. Prenat Diagn 2000; 20: 229-34.
60. Winichagoon P, Svasti S, Munkongdee T, Chaiya W, Boonmongkol P, Chantrakul N, et al. Rapid diagnosis of thalassemias and other hemoglobinopathies by capillary electrophoresis system. Transl Res 2008; 152: 178-84.
61. Kulapongs P, Sanguansermsri T, Mertz G, Tawarat S. Dichlorophenolindophenol (DCIP) precipitation test: a new screening test for Hb E and H. Pediatr Soc Thailand 1976; 15: 1-7.
62. Kattamis C, Efremov G, Pootrakul S. Effectiveness of one tube osmotic fragility screening in detecting β-thalassemia trait. J Met Genet 1981; 18: 266-70.
63. Pintar J, Skikne BS, Cook JD. A screening test for assessing iron status. Blood 1982; 59: 110-3.
64. Fucharoen G, Sanchaisuriya K, Sae-Ung N, Dangwibul S, Fucharoen S. A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in south-east Asia. Bull World Health Organ 2004; 82: 364-72.
65. WHO. World Health Assembly Resolution on Genomics and World Health. WHA57 13 WHO, Geneva, Switzerland. Available from: www.who/int.gb.